Effects of the SGLT-2 Inhibitor Canagliflozin on Adenine-Induced Chronic Kidney Disease in Rats

• Badreldin H. Ali,
• Suhail Al Salam,
• Yousuf Al Suleimani,
• Mohammed Al Za'abi,
• Aly M. Abdelrahman,
• Mohammed Ashique,
• Priyadarsini Manoj,
• Sirin A. Adham,
• Christina Hartmann,
• Nicole Schupp,
• Abderrahim Nemmar

Affiliations

Badreldin H. Ali

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Suhail Al Salam

Department of Pathology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates

Yousuf Al Suleimani

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Mohammed Al Za'abi

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Aly M. Abdelrahman

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Mohammed Ashique

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Priyadarsini Manoj

Department of Pharmacology and Clinical Pharmacy, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, Oman

Sirin A. Adham

Department of Biology, College of Science, Sultan Qaboos University, Muscat, Oman

Christina Hartmann

Institute of Toxicology, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany

Nicole Schupp

Institute of Toxicology, Medical Faculty, University of Düsseldorf, Düsseldorf, Germany

Abderrahim Nemmar

Department of Physiology, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates